National Resilience, LLC.
Latest round
- Series B
Last raised
- Oct 2020
Total raised
- $755M
Investors
- 6
About National Resilience, LLC.
Founded in 2020 by Drew Oetting and Rahul Singhvi, and based in Blue Ash, OH, National Resilience, Inc. specializes in biomanufacturing solutions for complex medicines, particularly in cell and gene therapies, biologics, and viral vector production. It operates as a Contract Development and Manufacturing Organization (CDMO) focusing on biomanufacturing solutions for complex medicines, particularly in the realms of cell and gene therapies, biologics, and viral vector production. National Resilience, Inc.S. Department of Defense.11 billion. Its principal offerings, such as Sprout Solutions™, DAR-T™, and Auto-T™, cater to the entire lifecycle of drug development—from initial concept to clinical readiness—by providing tailored manufacturing solutions that enhance transparency, speed, and scalability. The company’s robust capabilities encompass PAD and GMP manufacturing for monoclonal antibodies and recombinant proteins, as well as specialized facilities for AAV and LVV viral vector production., Europe, Asia, and the Middle East, who seek to leverage Resilience's advanced technologies and expertise to accelerate their therapeutic innovations. Resilience generates revenue through a variety of transaction structures primarily focused on B2B relationships with pharmaceutical and biotechnology companies. Clients engage with Resilience for services that include drug substance manufacturing and fill/finish operations, often structured as project-based contracts or long-term partnerships. Key offerings such as the Essential AAV & LVV program and Build Your Resilience™ provide clients with access to critical drug manufacturing support under customized terms. The revenue model is characterized by agreements that prioritize flexibility to meet specific project needs, often involving comprehensive quality assurance and supply chain management. These partnerships are designed to ensure that clients receive the necessary resources and support while enhancing the overall efficiency of their drug development processes.
Who invested in National Resilience, LLC.
6 investors across 1 round
See all investors in National Resilience, LLC.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 23, 2020
Amount
$755M
Investors
Questions about National Resilience, LLC.
Who invested in National Resilience, LLC.?
National Resilience, LLC. has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has National Resilience, LLC. raised?
National Resilience, LLC. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did National Resilience, LLC. last raise money?
National Resilience, LLC.'s most recent round on record is a Series B, in Oct 2020.
What does National Resilience, LLC. do?
Founded in 2020 by Drew Oetting and Rahul Singhvi, and based in Blue Ash, OH, National Resilience, Inc.
Where is National Resilience, LLC. headquartered?
National Resilience, LLC. is headquartered in Blue Ash, US.
Which VCs invest in companies like National Resilience, LLC.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at National Resilience, LLC.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like National Resilience, LLC.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.